STEVANATO GROUP SPA O.N. Cash Flow Conversion Efficiency
STEVANATO GROUP SPA O.N. cash flow conversion efficiency. Based on the latest financial reports, STEVANATO GROUP SPA O.N. (87N) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€31.86 Million ≈ $37.25 Million USD) by net assets (€1.55 Billion ≈ $1.81 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of STEVANATO GROUP SPA O.N. (2021–2025)
Cash flow conversion efficiency of STEVANATO GROUP SPA O.N. from 2021 to 2025. This chart illustrates how STEVANATO GROUP SPA O.N.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest STEVANATO GROUP SPA O.N. stock price today for real-time trading data and today's change.
STEVANATO GROUP SPA O.N. Cash Flow Conversion Ratio Explained
STEVANATO GROUP SPA O.N. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
STEVANATO GROUP SPA O.N. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STEVANATO GROUP SPA O.N. ranked by their cash flow conversion efficiency. Also see 87N market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LegalZoom.com Inc
NASDAQ:LZ
|
0.322x |
|
Jiangsu SOPO Chemical Co Ltd
SHG:600746
|
0.039x |
|
SDI Corp
TW:2351
|
0.077x |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
1.808x |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
0.123x |
|
Suofeiya Home Collection Co Ltd
SHE:002572
|
-0.038x |
|
Ranhill Holdings Ltd
KLSE:5272
|
0.153x |
|
Helia Group Ltd
AU:HLI
|
-0.038x |
Annual Cash Flow Conversion Efficiency for STEVANATO GROUP SPA O.N. (2021–2025)
The table below shows the annual cash flow conversion efficiency of STEVANATO GROUP SPA O.N. from 2021 to 2025. Review STEVANATO GROUP SPA O.N. free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €1.49 Billion ≈ $1.74 Billion |
€286.08 Million ≈ $334.45 Million |
0.192x | +73.50% |
| 2024-12-31 | €1.40 Billion ≈ $1.64 Billion |
€155.78 Million ≈ $182.12 Million |
0.111x | +19.41% |
| 2023-12-31 | €1.13 Billion ≈ $1.32 Billion |
€105.21 Million ≈ $123.00 Million |
0.093x | -10.46% |
| 2022-12-31 | €995.91 Million ≈ $1.16 Billion |
€103.31 Million ≈ $120.78 Million |
0.104x | -34.52% |
| 2021-12-31 | €841.66 Million ≈ $983.99 Million |
€133.34 Million ≈ $155.88 Million |
0.158x | -- |
About STEVANATO GROUP SPA O.N.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more